| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/15/1996 | EP0711282A1 Compounds as pde iv and tnf inhibitors |
| 05/15/1996 | EP0462182B1 Matrix metalloproteinase peptides: role in diagnosis and therapy |
| 05/15/1996 | CN1122337A Stable crystalline (6S)-and (6R)-tetrahydrofolic acid |
| 05/09/1996 | WO1996013603A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4 |
| 05/09/1996 | WO1996013517A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases |
| 05/09/1996 | WO1996013478A1 Mono- or polyenic carboxylic acid derivative |
| 05/09/1996 | WO1996013266A1 Boronic ester and acid compounds, synthesis and uses |
| 05/09/1996 | CA2202988A1 Mono- or polyenic carboxylic acid derivatives |
| 05/09/1996 | CA2173874A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases |
| 05/08/1996 | EP0710657A1 Antagonists of adhesion receptors |
| 05/08/1996 | EP0710239A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 05/08/1996 | CN1121823A Method for producing medicine for treatment of chronic osteomyelitis |
| 05/02/1996 | WO1996012742A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 05/02/1996 | WO1996012741A1 Binding agents to cd23 |
| 05/02/1996 | WO1996012501A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2 |
| 05/02/1996 | CA2203364A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 05/02/1996 | CA2203363A1 Binding agents to cd23 |
| 05/01/1996 | EP0708768A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 05/01/1996 | EP0708648A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid |
| 05/01/1996 | CN1121693A Oesteoblast growth stimulating composition containing PDGF and vitamin D |
| 04/30/1996 | US5512581 Antiinflammatory agent |
| 04/30/1996 | US5512570 Treatment of emesis with morpholine tachykinin receptor antagonists |
| 04/30/1996 | US5512552 Bone resorption inhibitor; osteoporosis |
| 04/25/1996 | WO1996011685A2 Use of indole derivatives for the treatment of various diseases |
| 04/24/1996 | WO1997014681A1 Heterocyclic compounds as h+-atpases |
| 04/24/1996 | EP0707850A1 Use of polyunsaturated fatty acids for the manufacture of a medicament for the treatment of brest pain |
| 04/24/1996 | EP0707566A1 Novel structural analogues of vitamin d |
| 04/24/1996 | CN1121074A Novel N-pyridyl carboxamides and derivatives, processes for their preparation and the pharmaceutical compositions which contain them |
| 04/23/1996 | US5510498 Benzothiophene compounds, intermediates, compositions, and methods |
| 04/23/1996 | US5510370 Osteoporosis, osteoarthritis treatment |
| 04/23/1996 | US5510358 Osteoporosis |
| 04/23/1996 | US5510357 Benzothiophene compounds as anti-estrogenic agents |
| 04/17/1996 | CN1120549A Calcitonin analogue and use thereof |
| 04/17/1996 | CN1031570C Process for preparation of pyrazolopyridine compound |
| 04/11/1996 | WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof |
| 04/10/1996 | EP0705839A1 Imidobisphosphoric acids, process for their preparation and their use |
| 04/10/1996 | EP0705827A1 Interleukin-1 inhibiting manumycin derivatives and streptomyces strains for their production |
| 04/10/1996 | CN1120337A Process for production of an imidazole derivative |
| 04/10/1996 | CN1120314A Method and composition for treatment of osteoporosis |
| 04/10/1996 | CN1120304A Method and composition for treatment of osteoporosis |
| 04/10/1996 | CN1120039A Acylated aminoalknimidazoles and-triazoles |
| 04/10/1996 | CN1119940A Combination treatment for inhibiting bone loss |
| 04/09/1996 | US5506249 Antiinflammatory, antiproliferative and antitumor activity |
| 04/09/1996 | US5506243 Sulfonamide derivatives |
| 04/09/1996 | US5506242 Arylsufonamido-substituted hydroxamic acids |
| 04/09/1996 | US5506133 Polypeptide |
| 04/04/1996 | WO1996009819A1 Inhibitor for bone resorption by osteoclast |
| 04/03/1996 | EP0704219A2 A novel osteoblastic proliferative factor |
| 04/03/1996 | EP0704218A2 Bone reinforcing agent and foods and drinks product containing the same |
| 04/03/1996 | EP0703897A1 Lipoxin compounds |
| 04/03/1996 | EP0703785A1 Methods for treating muscle diseases and disorders |
| 04/03/1996 | EP0535091B1 Osteoinductive pharmaceutical formulations |
| 04/03/1996 | CN1119530A Methods of use for inhibiting bone loss and lowering serum cholesterol |
| 03/31/1996 | CA2159257A1 Interleukin-1 production inhibiting compound |
| 03/28/1996 | WO1996009074A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 03/28/1996 | WO1996009039A1 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 03/28/1996 | WO1996009036A1 Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof |
| 03/28/1996 | CA2200835A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 03/28/1996 | CA2200449A1 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 03/27/1996 | EP0703228A1 Naphthyl compounds, intermediates, processes, compositions involving them |
| 03/27/1996 | EP0702954A2 Calcium dietary supplement |
| 03/27/1996 | EP0702559A1 Multiple botulinum toxins for treating neuromuscular disorders and conditions |
| 03/27/1996 | EP0702551A1 Compositions and methods for reparation and prevention of fibrotic lesions |
| 03/27/1996 | CN1119457A Bone stimulating factor |
| 03/27/1996 | CA2158811A1 Calcium dietary supplement |
| 03/26/1996 | US5501969 Bone disorders, antitumor |
| 03/26/1996 | US5501861 Carbohydrates |
| 03/22/1996 | CA2158591A1 Fatty acid treatment |
| 03/21/1996 | WO1996008480A1 Neurokinin antagonists |
| 03/21/1996 | CA2200083A1 Neurokinin antagonists |
| 03/20/1996 | EP0702010A1 Benzopyranderivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/20/1996 | EP0701568A1 New peptide derivatives |
| 03/20/1996 | EP0701449A1 Process for the preparation of an oral solid dosage form containing diclofenac |
| 03/19/1996 | US5500429 Cardiovascular |
| 03/14/1996 | WO1996007418A1 Phosphonates and parathyroid hormone for osteoporosis |
| 03/14/1996 | WO1996007417A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone |
| 03/14/1996 | WO1996007416A1 Estrogens and parathyroid hormone for treating osteoporosis |
| 03/14/1996 | WO1996007402A1 Triphenylethylenes for the prevention and treatment of osteoporosis |
| 03/14/1996 | CA2199252A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone |
| 03/14/1996 | CA2199251A1 Phosphonates and parathyroid hormone for osteoporosis |
| 03/14/1996 | CA2199250A1 Estrogens and parathyroid hormone for treating osteoporosis |
| 03/13/1996 | EP0544880B1 Method of preparing diacetyl rhein |
| 03/12/1996 | US5498617 Bone disorders |
| 03/07/1996 | WO1996006941A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle |
| 03/07/1996 | CA2198462A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle |
| 03/06/1996 | EP0699673A1 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents |
| 03/06/1996 | EP0699672A1 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents |
| 03/05/1996 | US5496814 Steroids for bone disorders and oxidation resistance |
| 03/05/1996 | US5496801 Storage stability, mannitol, citric acid buffer |
| 03/01/1996 | CA2157236A1 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents |
| 03/01/1996 | CA2157235A1 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents |
| 02/29/1996 | WO1996006169A1 Human chemokine beta-9 |
| 02/29/1996 | WO1996006087A1 Bicyclic compounds |
| 02/29/1996 | WO1996005855A1 Cartilage disease remedy |
| 02/29/1996 | WO1996005851A1 Use of tasteless, hydrolysed collagen and agent containing the same |
| 02/29/1996 | WO1996005842A1 Intravenous alendronate formulations |
| 02/29/1996 | WO1996005829A1 Methods of maintaining teeth and oral bone |
| 02/29/1996 | CA2198206A1 Human chemokine beta-9 |
| 02/29/1996 | CA2198108A1 Methods of maintaining teeth and oral bone |
| 02/28/1996 | EP0698094A1 Bmp-11 compositions |